Results 11 to 20 of about 38,180 (186)

Factor V Leiden Mutation in Iraqi Patients with Deep Venous Thrombosis.

مجلة كلية الطب, 2011
Background: Factor V Leiden is considered the most common inherited risk factor for venous thrombosis in Caucasian populations, including those in the Eastern Mediterranean region.
Nasir Al‐Allawi, Jaladet Jubrael, Ferial A. Hilmi   +2 more
openalex   +3 more sources

Current evidence for outcomes of free-flap reconstruction in factor V Leiden patients

Australasian Journal of Plastic Surgery, 2019
**Background**: Factor V Leiden is the most common form of inherited thrombophilic syndrome, affecting 5 per cent of Caucasians. While increased rates of venous thromboembolic complications have been regularly reported in factor V Leiden patients, little
Isobel Yeap, Chris S. Ahn, Stuart Hoffman, Rowan Gillies, John Vandervord   +4 more
openalex   +3 more sources

FACTOR V LEIDEN AND THROMBOEMBOLISM [PDF]

Basrah Journal of Surgery, 2004
Zuhair Al-Barazanchi
openaire   +2 more sources

Fator V de Leiden Factor V Leiden

Revista Brasileira de Hematologia e Hemoterapia, 2005
José M. P. Godoy
openaire   +3 more sources

A Rare Case of Quadruple Limb Amputation due to Factor V Leiden Mutation

Indian Journal of Physical Medicine & Rehabilitation, 2022
Factor V Leiden, an autosomal dominant gene mutation that leads to increase risk of forming thrombophilia. Amputation in patients with Factor V leiden mutation is known but none describe quad-limb amputation in this setting.
Ann Noble Zachariah, Ravi Sankaran
doaj   +1 more source

Risk of venous thromboembolism in association with factor V leiden in cancer patients - The EDITH case-control study. [PDF]

PLoS ONE, 2018
Cancer and factor V Leiden mutation are both risk factors for venous thromboembolism (VTE). Cancer critically increases the thrombotic risk whereas Factor V Leiden is the most common pro-thrombotic mutation.
Adeline Heraudeau, Aurélien Delluc, Mickaël Le Henaff, Karine Lacut, Christophe Leroyer, Benoit Desrues, Francis Couturaud, Cécile Tromeur   +7 more
doaj   +1 more source

Comparative analysis of “APTT vs RVVT” based activated protein C resistance assay in the diagnosis of Factor V Leiden mutation

Indian Journal of Pathology and Microbiology, 2020
Background: Thrombophilia is a hypercoagulable state characterized by increased venous thrombosis. The most common cause of heritable thrombophilia is Factor V Leiden (FVR506Q) homozygous state, with a relative risk of 10–80 times as compared to normal ...
Mirza Asif Baig
doaj   +1 more source

Recurrent pregnancy loss: can factor V Leiden mutations be a cause [PDF]

Obstetrics & Gynecology Science, 2019
The role of Factor V Leiden (FVL) mutation in recurrent miscarriages has been disputed. It has been hypothesized that FVL mutation in patients with recurrent miscarriages is treatable.
R R N Reddy, Deepti Mutreja, Nikhil Moorchung, Indrayani Mukhopadhyay   +3 more
doaj   +1 more source

Avascular necrosis in systemic lupus erythematosus: total hip replacement in a patient with mutation in clotting factor V (Leiden) gene, clinical observation

Современная ревматология, 2021
The article provides a description of the systemic lupus erythematosus patient with multiple avascular bone necrosis (ABN), homozygous mutation in clotting factor V (Leiden) gene, who successfully underwent the total hip replacement.
F. A. Cheldieva, I. G. Kushnareva, V. V. Babak, A. E. Khramov, T. M. Reshetnyak   +4 more
doaj   +1 more source

Is Factor V Leiden a Risk Factor for Fetal Loss?

Acta Medica, 1999
A successful pregnancy is dependent on the development of adequate placental circulation. The abnormalities of placental vasculature may result in a number of gestational pathologies, including fetal loss.
Petr Dulíček, Ladislav Chrobák, Ivo Kalousek, Lenka Pešavová, Miroslav Pecka, Pravoslav Stránský   +5 more
doaj   +1 more source